<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Haemophilus influenzae</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Haemophilus influenzae.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/haemophilus-influenzae.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Haemophilus influenzae global epidemiology and antimicrobial susceptibility patterns including ampicillin and amoxicillin-clavulanate resistance based on β-lactamase production, 2013–2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-11438-9-fe5e80e6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-11438-9-fe5e80e6/</guid>
    <pubDate>Thu, 23 Oct 2025 00:00:00 GMT</pubDate>
    <description>The findings indicate geographic variation in H. influenzae antimicrobial resistance and differences associated with beta-lactamase production. The authors state that these results support reliable susceptibility testing and resistance-containment efforts, while the abstract reports caution regarding clarithromycin in settings with high resistance.</description>
    <category>Haemophilus influenzae</category>
    <category>Antimicrobial resistance</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Use of Haemophilus influenzae Type b–Containing Vaccines Among American Indian and Alaska Native Infants: Updated Recommendations of the Advisory Committee on Immunization Practices ― United States, 2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7336a4-a64084d7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7336a4-a64084d7/</guid>
    <pubDate>Thu, 12 Sep 2024 00:00:00 GMT</pubDate>
    <description>The guideline addresses a health disparity by offering AI/AN communities an additional vaccine option that maintains early protection against invasive Hib disease while simplifying infant immunization schedules through a combination vaccine. It may improve vaccine uptake and coverage in a high-risk population.</description>
    <category>Haemophilus influenzae</category>
    <category>Influenza</category>
    <category>Hepatitis B</category>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-024-01192-6-d22e9b1f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-024-01192-6-d22e9b1f/</guid>
    <pubDate>Wed, 13 Mar 2024 00:00:00 GMT</pubDate>
    <description>The editorial addresses vaccine coverage equity and integration of WHO-recommended vaccines into national programs, with implications for middle-income countries facing vaccine financing and delivery challenges. Findings emphasize government leadership and strategic policymaking to achieve universal vaccine coverage and global health goals.</description>
    <category>COVID-19</category>
    <category>Haemophilus influenzae</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Health policy</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2015-11-060-218332a8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2015-11-060-218332a8/</guid>
    <pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
    <description>The findings suggest carriage surveillance can assess vaccine effects on circulating pathogens, evaluate pneumococcal conjugate vaccine impact, and predict changes in respiratory and invasive disease. A potential new equilibrium between non-vaccine pneumococcal serotypes and other pathogenic bacteria may be emerging in the post-PCV era.</description>
    <category>Haemophilus influenzae</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2006-04-021-98b3765e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2006-04-021-98b3765e/</guid>
    <pubDate>Thu, 01 Jun 2006 00:00:00 GMT</pubDate>
    <description>The paper is relevant to understanding why Hib vaccine responses may differ between populations and why some vaccinated individuals may have weaker antibody responses. It is an immunogenicity study rather than a direct assessment of disease burden.</description>
    <category>Haemophilus influenzae</category>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
